Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intravesical Botox pilot study in newborns with myelomeningocele
NL-OMON27522Recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in spina bifida (SB) and neurogenic bladder (2 arms), sponsored by Erasmus MC. Primary endpoint: End filling pressure of the bladder. Started Jun 2014; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
spina bifida (SB)neurogenic bladder
Beyond the preview
Go deeper on NL-OMON27522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27522.